These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29455270)

  • 1. Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse.
    Larsen TR; McMunn J; Ahmad H; AlMahameed ST
    Drug Saf Case Rep; 2018 Feb; 5(1):11. PubMed ID: 29455270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not your regular high: cardiac dysrhythmias caused by loperamide.
    Wightman RS; Hoffman RS; Howland MA; Rice B; Biary R; Lugassy D
    Clin Toxicol (Phila); 2016 Jun; 54(5):454-8. PubMed ID: 27022002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic Abnormalities, Malignant Ventricular Arrhythmias, and Cardiomyopathy Associated With Loperamide Abuse.
    Vaughn P; Solik MM; Bagga S; Padanilam BJ
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1230-1233. PubMed ID: 27461785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loperamide-induced cardiotoxicity: a case overlooked?
    Iqbal S; Fayyaz SM; Saeed Y; Aqeel M
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34290024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected Serious Cardiac Arrhythmias in the Setting of Loperamide Abuse.
    Rasla S; Parikh P; Hoffmeister P; St Amand A; Garas MK; El Meligy A; Minami T; Shah NR
    R I Med J (2013); 2017 Apr; 100(4):33-36. PubMed ID: 28375418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Review: Loperamide Toxicity.
    Wu PE; Juurlink DN
    Ann Emerg Med; 2017 Aug; 70(2):245-252. PubMed ID: 28506439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk.
    Lee VR; Vera A; Alexander A; Ruck B; Nelson LS; Wax P; Campleman S; Brent J; Calello DP
    Clin Toxicol (Phila); 2019 Mar; 57(3):175-180. PubMed ID: 30585509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic changes in loperamide toxicity: Case report and review of literature.
    Teigeler T; Stahura H; Alimohammad R; Kalahasty G; Koneru JN; Ellenbogen M; Ellenbogen KA; Padala SK
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2618-2626. PubMed ID: 31432581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Cardiac Lesion with Chronic and Acute Use of Loperamide-An Integrative Review.
    Lammoglia BC; Hasselmann G; Pires-Oliveira M; Duarte Nicolau LA; Rolim Medeiros JV; Sabia Tallo F; Omar Taha M; Yamaguti Lima R; Caricati-Neto A; Menezes-Rodrigues FS
    J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loperamide-induced cardiogenic syncope: a case report of a life-threatening presentation of an over-the-counter drug.
    Hegde V; Dalia T; Tayeb T; Cotter E; Vidic A
    Eur Heart J Case Rep; 2023 Feb; 7(2):ytad059. PubMed ID: 36819880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ' Loperamide overdose induces ventricular tachycardia with catastrophic outcomes'.
    Ali Z; Shoukat U; Khan M; Roomi S; Ullah W
    J Community Hosp Intern Med Perspect; 2020 Jun; 10(3):229-232. PubMed ID: 32850070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Ventricular Tachycardia After Prophylactic Doses of Droperidol in Patients With Mild QT Interval Prolongation Due to Preoperative Medication.
    Takechi K; Shimizu I
    Cureus; 2021 Jun; 13(6):e15560. PubMed ID: 34277183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of an ECG record database reveals QT interval prolongation potential of famotidine in a large Korean population.
    Yun J; Hwangbo E; Lee J; Chon CR; Kim PA; Jeong IH; Park M; Park R; Kang SJ; Choi D
    Cardiovasc Toxicol; 2015 Apr; 15(2):197-202. PubMed ID: 25253561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
    Uvelin A; Pejaković J; Mijatović V
    J Anesth; 2017 Jun; 31(3):413-423. PubMed ID: 28229241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.
    Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL
    J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loperamide Induced Life Threatening Ventricular Arrhythmia.
    Upadhyay A; Bodar V; Malekzadegan M; Singh S; Frumkin W; Mangla A; Doshi K
    Case Rep Cardiol; 2016; 2016():5040176. PubMed ID: 27547470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loperamide abuse cardiotoxicity. Should loperamide still be an over the counter medication?
    Idris A; Mihora DC; Kaye K
    Am J Emerg Med; 2018 Sep; 36(9):1716.e1-1716.e3. PubMed ID: 29779679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loperamide-induced ventricular tachycardia storm.
    Daoub M; Cawley P; Sahu J
    Br J Cardiol; 2021; 28(4):46. PubMed ID: 35747063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loperamide metabolite-induced cardiomyopathy and QTc prolongation.
    Bhatti Z; Norsworthy J; Szombathy T
    Clin Toxicol (Phila); 2017 Aug; 55(7):659-661. PubMed ID: 28349724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use.
    Chiu MH; Al-Majed NS; Stubbins R; Pollmann D; Sandhu RK
    BMC Res Notes; 2016 Jun; 9():310. PubMed ID: 27301406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.